Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Mubritinib
Trade Name
Synonyms TAK165|TAK 165|TAK-165
Drug Descriptions

Mubritinib (TAK-165) selectively inhibits ERBB2 (HER2), potentially resulting in oxidative stress, apoptosis (PMID: 31287994), decreased tumor cell viability (PMID: 34715459), and reduced tumor cell proliferation and tumor growth (PMID: 16771730).

DrugClasses HER2 Inhibitor 40
CAS Registry Number 366017-09-6
NCIT ID C66212

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Mubritinib Mubritinib 0 0
Mubritinib + Sotorasib Mubritinib Sotorasib 0 0


Additional content available in CKB BOOST